Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumors.
Year: 1996
Type: article
Source: PubMed
Authors: A Cesano, S Visonneau, K A Jeglum, J Owen, K Wilkinson, K Carner, L Reese, D Santoli
Institution: The Wistar Institute
Language: English
Topic: Veterinary Oncology Research
Subfield: Small Animals
Field: Veterinary
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2145045134
